These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4778588)

  • 21. The chemotherapy of rodent malaria. XIV. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites. 4. The response of normal and drug-resistant strains of Plasmodium berghei.
    Peters W
    Ann Trop Med Parasitol; 1971 Jun; 65(2):123-9. PubMed ID: 5090256
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver enzyme induction by anticonvulsant drugs, and its relationship to disturbed calcium and folic acid metabolism.
    Latham AN; Millbank L; Richens A; Rowe DJ
    J Clin Pharmacol; 1973; 13(8):337-42. PubMed ID: 4199214
    [No Abstract]   [Full Text] [Related]  

  • 23. [Criteria for the selection of sulfonamides for the treatment of rodent malaria (Plasmodium vinckei)].
    Heischkeil R
    Z Tropenmed Parasitol; 1972 Jun; 23(2):128-43. PubMed ID: 5050535
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyrimethamine effect on folate metabolism.
    Herbert V; Waxman S
    N Engl J Med; 1969 Sep; 281(10):564-5. PubMed ID: 5800521
    [No Abstract]   [Full Text] [Related]  

  • 25. [Causal preventive activity of standard antimalarials in rodent malaria (Plasmodium berghei yoelii)].
    Fink E
    Z Tropenmed Parasitol; 1972 Mar; 23(1):35-48. PubMed ID: 5050530
    [No Abstract]   [Full Text] [Related]  

  • 26. [In vitro sensitivity of Plasmodium falciparum to anti-folinic agents (trimethoprim, pyrimethamine, cycloguanil): a study of 29 African strains].
    Basco LK; Le Bras J
    Bull Soc Pathol Exot; 1997; 90(2):90-3. PubMed ID: 9289260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage sensitivity of Plasmodium vinckei petteri to quinine, mefloquine, and pyrimethamine.
    Caillard V; Beauté-Lafitte A; Chabaud A; Ginsburg H; Landau I
    J Parasitol; 1995 Apr; 81(2):295-301. PubMed ID: 7707210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some studies on the convulsant action of folic acid.
    Baxter MG; Miller AA; Webster RA
    Br J Pharmacol; 1973 Jun; 48(2):350P-351P. PubMed ID: 4733748
    [No Abstract]   [Full Text] [Related]  

  • 29. Folic acid deficiency complicating malaria.
    Strickland GT; Kostinas JE
    Am J Trop Med Hyg; 1970 Nov; 19(6):910-5. PubMed ID: 4923968
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic and molecular properties of the dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant clones of the human malaria parasite Plasmodium falciparum.
    Chen GX; Mueller C; Wendlinger M; Zolg JW
    Mol Pharmacol; 1987 Apr; 31(4):430-7. PubMed ID: 3553892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anticonvulsants and methotrexate on calcium disposition.
    Evans MA
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):63-7. PubMed ID: 7242694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiating action of sulfalene-pyrimethamine mixtures against drug-resistant strains of Plasmodium berghei.
    Peters W
    Chemotherapy; 1971; 16(6):389-98. PubMed ID: 5145011
    [No Abstract]   [Full Text] [Related]  

  • 33. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitr.
    Gutteridge WE; Trigg PI
    Parasitology; 1971 Jun; 62(3):431-44. PubMed ID: 4997058
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytotoxicity, uptake, polyglutamate formation, and antileukemic effects of 8-deaza analogues of methotrexate and aminopterin in mice.
    Kuehl M; Brixner DI; Broom AD; Avery TL; Blakley RL
    Cancer Res; 1988 Mar; 48(6):1481-8. PubMed ID: 2449950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chemotherapy of rodent malaria, 8. The action of some sulphonamides alone or with folic reductase inhibitors against malaria vectors and parasites, part 3: the action of sulphormethoxine and pyrimethamine on the sporogonic stages.
    Ramkaran AE; Peters W
    Ann Trop Med Parasitol; 1969 Dec; 63(4):449-54. PubMed ID: 5384694
    [No Abstract]   [Full Text] [Related]  

  • 36. Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malaria.
    McKie JH; Douglas KT; Chan C; Roser SA; Yates R; Read M; Hyde JE; Dascombe MJ; Yuthavong Y; Sirawaraporn W
    J Med Chem; 1998 Apr; 41(9):1367-70. PubMed ID: 9554869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of new antimalarial drugs sulfonamides and trimethoprim.
    Aviado DM; Singh G; Berkley R
    Chemotherapy; 1969; 14(1):37-53. PubMed ID: 5814488
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of milk diet on strains of Plasmodium berghei Vincke and Lips 1948 sensitive or resistant to pyrimethamine in white mice].
    Vray B
    Ann Parasitol Hum Comp; 1970; 45(2):169-82. PubMed ID: 5474513
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of certain anticonvulsants on the concentration of -aminobutyric acid in the cerebral hemispheres of mice.
    Saad SF; el-Masry AM; Scott PM
    Eur J Pharmacol; 1972 Mar; 17(3):386-92. PubMed ID: 5022154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.